182 related articles for article (PubMed ID: 19096126)
1. Expression of hypoxia-inducible factor (HIF)-1alpha and vascular endothelial growth factor (VEGF)-D as outcome predictors in resected esophageal squamous cell carcinoma.
Tzao C; Lee SC; Tung HJ; Hsu HS; Hsu WH; Sun GH; Yu CP; Jin JS; Cheng YL
Dis Markers; 2008; 25(3):141-8. PubMed ID: 19096126
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of hypoxia-inducible factor 1α, and its correlation with p53 and vascular endothelial growth factor expression in resectable esophageal squamous cell carcinoma.
Shao N; Han Y; Song L; Song W
J Cancer Res Ther; 2020; 16(2):269-275. PubMed ID: 32474512
[TBL] [Abstract][Full Text] [Related]
3. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
Yu ZT; Zhao HF; Shang XB
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625
[TBL] [Abstract][Full Text] [Related]
4. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer.
Katsuta M; Miyashita M; Makino H; Nomura T; Shinji S; Yamashita K; Tajiri T; Kudo M; Ishiwata T; Naito Z
Exp Mol Pathol; 2005 Apr; 78(2):123-30. PubMed ID: 15713437
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of HIF-1α and esophageal squamous cell carcinoma (ESCC) risk.
Sun G; Hu W; Lu Y; Wang Y
Pathol Oncol Res; 2013 Oct; 19(4):685-93. PubMed ID: 23658132
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer].
Honguero Martínez AF; Arnau Obrer A; Figueroa Almazán S; Martínez Hernández N; Guijarro Jorge R
Med Clin (Barc); 2014 May; 142(10):432-7. PubMed ID: 23948151
[TBL] [Abstract][Full Text] [Related]
7. Increased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patients.
Zhang L; Ye SB; Li ZL; Ma G; Chen SP; He J; Liu WL; Xie D; Zeng YX; Li J
Int J Clin Exp Pathol; 2014; 7(7):3887-97. PubMed ID: 25120765
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of hypoxia-inducible-factor 1alpha(HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage.
Kurokawa T; Miyamoto M; Kato K; Cho Y; Kawarada Y; Hida Y; Shinohara T; Itoh T; Okushiba S; Kondo S; Katoh H
Br J Cancer; 2003 Sep; 89(6):1042-7. PubMed ID: 12966423
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of thymosin β4, vascular endothelial growth factor (VEGF), and hypoxia inducible factor (HIF)-1α in early-stage cervical cancers.
Kim NS; Kang YJ; Jo JO; Kim HY; Oh YR; Kim YO; Jung MH; Ock MS; Cha HJ
Pathol Oncol Res; 2011 Sep; 17(3):493-502. PubMed ID: 21213129
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between hypoxia inducible factor-1α and esophageal squamous cell carcinoma: a meta analysis].
Jing S; Wang J; Liu Q; Cheng Y; Yang C; Wang Y; Cao F; Wen B; Jiao W; Guo Y
Zhonghua Bing Li Xue Za Zhi; 2014 Sep; 43(9):593-9. PubMed ID: 25471499
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor 1α in combination with vascular endothelial growth factor could predict the prognosis of postoperative patients with oesophageal squamous cell cancer.
Shao JB; Li Z; Zhang N; Yang F; Gao W; Sun ZG
Pol J Pathol; 2019; 70(2):84-90. PubMed ID: 31556558
[TBL] [Abstract][Full Text] [Related]
12. Prognostic values of STAT3 and HIF-1α in esophageal squamous cell carcinoma.
Zhao X; Tang YP; Wang CY; Wu JX; Ye F
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3351-3357. PubMed ID: 31081089
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between the expression of hypoxia-inducible factor-1alpha and chemotherapy response in esophageal squamous cell carcinoma].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1783-5. PubMed ID: 17919389
[TBL] [Abstract][Full Text] [Related]
14. [Expression and biological significance of HPA and HIF-1alpha in human esophageal squamous cell carcinoma].
Liu JL; Zhou BJ; Zhang Y; Wu YP; Liu SZ; G A O WM; Xue J; Liu WH
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):689-92. PubMed ID: 18246800
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53 protein in esophageal squamous cell carcinoma: relation to hypoxia-inducible factor-1alpha, angiogenesis and apoptosis.
Kimura S; Kitadai Y; Kuwai T; Tanaka S; Hihara J; Yoshida K; Toge T; Chayama K
Pathobiology; 2005; 72(4):179-85. PubMed ID: 16127293
[TBL] [Abstract][Full Text] [Related]
16. Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma.
Shirakawa M; Fujiwara Y; Sugita Y; Moon JH; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Mori M; Doki Y
Oncol Rep; 2012 Apr; 27(4):940-6. PubMed ID: 22200953
[TBL] [Abstract][Full Text] [Related]
17. Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma.
Kimura S; Kitadai Y; Tanaka S; Kuwai T; Hihara J; Yoshida K; Toge T; Chayama K
Eur J Cancer; 2004 Aug; 40(12):1904-12. PubMed ID: 15288294
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
[TBL] [Abstract][Full Text] [Related]
19. Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression.
Chen Y; Lu Y; Lu C; Zhang L
Pathol Oncol Res; 2009 Sep; 15(3):487-93. PubMed ID: 19130303
[TBL] [Abstract][Full Text] [Related]
20. Expression of hypoxia-inducible factor-1alpha in esophageal squamous cell carcinoma.
Matsuyama T; Nakanishi K; Hayashi T; Yoshizumi Y; Aiko S; Sugiura Y; Tanimoto T; Uenoyama M; Ozeki Y; Maehara T
Cancer Sci; 2005 Mar; 96(3):176-82. PubMed ID: 15771621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
